Gaois

Cóip statach de shonraí a easpórtáiltear ó IATE ó am go chéile atá sa chnuasach seo. Níor cheart glacadh leis gurb ionann i gcónaí an t-eolas a thugtar faoi iontráil anseo agus a bhfuil sa leagan reatha den iontráil ar IATE. Is féidir an leagan reatha sin a cheadú ach cliceáil ar an nasc atá ar thaobh na láimhe deise ag barr gach iontrála. Breis eolais »

1 toradh

  1. SOCIAL QUESTIONS|health|pharmaceutical industry|pharmaceutical product
    leigheas bithchosúil Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    biosimilar medicinal product | biosimilar | similar biological medicinal product | similar biological | biosimilar medicine | biogeneric
    en
    Sainmhíniú biological medicine highly similar to another already approved biological medicine (the ‘reference medicine’) Tagairt "COMMISSION STAFF WORKING DOCUMENT IMPACT ASSESSMENT Accompanying the document Proposal for a Regulation of the European Parliament and of the Council amending Regulation (EC) No 469/2009 concerning the supplementary protection certificate for medicinal products"
    Nóta Unlike the small molecules of classical medicines, which are ‘chemically’ synthesised, the much more complex biosimilars are extracted or synthesised from biological sources such as blood or tissues, and for this reason cannot be fully identical to their reference products.
    biosimilaire | biogénérique | médicament biologique similaire
    fr